drugset / Trial / NCT07515820
SHR-3821 in Advanced Colorectal Cancer: an Exploratory Study
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the safety and efficacy of SHR-3821 combined with fruquintinib in the advanced colorectal cancer after failure of standard therapy
Timeline
- Start
- 2026-04-27
- Primary completion
- 2027-07-28
- Completion
- 2028-04-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fruquintinib | Small molecule | — | Oral |
| Subject | SHR-3821 | Unknown | — | Intravenous |